Biotech
MENLO PARK, CA: MENLO PARK, CA -- (Marketwire) -- 08/07/12 -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the t ...
MENLO PARK, CA: MENLO PARK, CA -- (Marketwire) -- 08/07/12 -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the t ...
HALIFAX, NOVA SCOTIA: Novel Cancer Immunotherapy Generates Polyfunctional T Cell Responses in Multiple Tumor Types; Triggers Increases in Antigen Targeted CD8+ T Cells ...
NEW YORK, NY: NEW YORK, NY -- (Marketwire) -- 08/06/12 -- Immunovative, Inc. ("IMUN") (OTCBB: IMUN) ("The Company") has today announced that it has successfully completed a $5,000,000 equity pr ...
BEVERLY, MA: BEVERLY, MA -- (Marketwire) -- 08/06/12 -- Cellceutix Corporation (OTCBB: CTIX) (the "Company"), a biopharmaceutical company focused on discovering small molecule drugs for hard to treat di ...
EDEN PRAIRIE, MN and SYDNEY, AUSTRALIA: EDEN PRAIRIE, MN and SYDNEY, AUSTRALIA -- (Marketwire) -- 08/06/12 -- Sunshine Heart, Inc. (NASDAQ: SSH) (ASX: SHC) announced today that it has received conditional approval from the United States Fo ...
SAN FRANCISCO, CA and TOKYO: SAN FRANCISCO, CA and TOKYO -- (Marketwire) -- 08/03/12 -- Medivation, Inc. (NASDAQ: MDVN) and Astellas Pharma Inc. (TSE: 4503) today announced that the U.S. Food and Drug Administration (FDA) has as ...
BOTHELL, WA: BOTHELL, WA -- (Marketwire) -- 08/03/12 -- Marina Biotech, Inc. (OTCQX: MRNA), a leading nucleic acid-based drug discovery and development company, announced today that it has entered into a licensin ...
MONTREAL, CANADA: MONTREAL, CANADA -- (Marketwire) -- 08/02/12 -- MethylGene Inc. (TSX: MYG) today reported financial results for the second quarter ended June 30, 2012 and provided an update on its clinical programs ...
SAN FRANCISCO, CA: SAN FRANCISCO, CA -- (Marketwire) -- 08/02/12 -- Medivation, Inc. (NASDAQ: MDVN) today announced that it will host a live teleconference with management to discuss second quarter 2012 financial resul ...
NEW YORK, NY: NEW YORK, NY -- (Marketwire) -- 08/02/12 -- Immunovative, Inc. ("IMUN") (OTCBB: IMUN) announces today the appointment of Dr. Zivile Katiliene as Director of Regulatory Affairs and Clinical ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwire) -- 08/02/12 -- Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) today reported financial results for the second quarter ended June 30, 2012. Revenue for the seco ...
MONTREAL, CANADA: MONTREAL, CANADA -- (Marketwire) -- 08/02/12 -- Paladin Labs Inc. (TSX: PLB), a leading specialty pharmaceutical company, today reported its financial results for the quarter ended June 30, 2012.201 ...
BERKELEY, CA: BERKELEY, CA -- (Marketwire) -- 08/01/12 -- Dynavax Technologies Corporation (NASDAQ: DVAX) today reported financial results for the second quarter ended June 30, 2012. The Company had $160.2 million ...
SAN FRANCISCO, CA: SAN FRANCISCO, CA -- (Marketwire) -- 08/01/12 -- announced today that it has updated coverage on (OTCBB: OHRP) ("The Company" or "OHR") and raised its twelve month target price ...
PRINCETON, NJ: PharmaVOICE 100 Recognizes Individuals for Positive Contributions to the Life Sciences Industry ...
SOUTH SAN FRANCISCO, CA: Company Updates Financial Guidance in Connection With Recent Financing and Announces Plans to Initiate Potential Registration Program for Tirasemtiv (CK-2017357) ...
IRVINE, CA: IRVINE, CA -- (Marketwire) -- 07/31/12 -- On the eve of its 10-year anniversary, reflects on a decade in the life sciences industry.Born in 2002, Enterey Life Sciences Consulting was the brainchild ...
